Gapping up
In reaction to earnings/guidance:
- SOFI +12.9%, UBER +9.6%, BCOR +8.9%, HOLX +8.4%, BSM +6%, AMKR +5%, ECVT +4.9%, PFE +4.7%, LSCC +4.5%, PLOW +4.1%, LEG +3.7%, CIVI +3.7%, WAT +3.6%, CAR +3.5%, ADUS +3.5%, ICPT +3.1%, SONY +3%, PACK +2.9%, IMAX +2.8%, MPLX +2.7%, STNG +2.7%, HSC +2.1%, ARCB +2%, VAL +1.6%, IDXX +1.6%, INCY +1.6%, MPC +1.5%, XYL +1.5%, NXPI +1.4%, WEC +1.3%, SIRI +1.3%, CINF +1.1%, LPX +1.1%
Other news:
- ABMD +51.7% (Johnson & Johnson to acquire Abiomed (AMBD) for $380/share in cash; expected to be accretive to adj. earnings beginning in 2024)
- LI +9.2% (October deliveries)
- NIO +7.1% (October deliveries)
- MLCO +7.1% (following Macau Gaming revs for October)
- XPEV +5.4% (October deliveries)
- LVS +4.7% (following Macau Gaming revs for October)
- RRGB +4.5% (CFO to retire)
- BZUN +4.3% (announces primary listing on the Main Board of The Stock Exchange of Hong Kong effective today)
- GME +3.7% (GameStop's NFT Marketplace launches with ImmutableX)
- ATCO +3.4% (to be acquired by Poseidon Acquisition Corp. for $15.50 in cash per share)
- IMO +3% (announces terms of its substantial issuer bid for up to $1.5 bln and receipt of exemptive relief)
- DEN +2.8% (executes CO2 Services Agreement with Clean Hydrogen Works)
- WYNN +2.8% (following Macau Gaming revs for October)
- KPTI +2.1% (EC grants orphan designation for selinexor for myelofibrosis)
- MGM +2% (following Macau Gaming revs for October)
- AZN +1.8% (reports Vaxzevria receives full Marketing Authorisation in the EU for the prevention of COVID-19)
- NVTA +1.6% (study shows therapy informed by genetic testing reduces seizures in some patients with epilepsy)
Analyst comments:
- FSLR +3% (upgraded to Equal Weight from Underweight at Barclays)
- NSC +3% (upgraded to Sector Perform from Underperform at RBC Capital Mkts)
- MNST +2.3% (upgraded to Overweight from Neutral at JP Morgan)
- LPLA +1.8% (upgraded to Outperform from Neutral at Credit Suisse)